Safe to Sleep
|
Public Education Campaign
|
CDC, HRSA
|
NICHD
|
1994
|
|
SARS-CoV-2 Assessment of Viral Evolution Program (SAVE)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, ASPR
|
NIAID
|
2021
|
|
SARS-CoV-2 evolution in immunocompromised people
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIAID
|
2022
|
|
SARS-CoV-2 Interagency Group on Resistance to Medical Countermeasures (MCMs)
|
Committee, Advisory Group, or Work Group
|
ASPR, CDC, FDA
|
|
2021
|
|
SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES)
|
Other
|
CDC
|
NIAID
|
2020
|
|
SEARCH for Diabetes in Youth (SEARCH)
|
Research Initiative
|
CDC
|
|
2001
|
|
Secretary's Advisory Committee on Infant Mortality
|
Committee, Advisory Group, or Work Group
|
CDC, HRSA
|
NICHD
|
1991
|
|
Sepsis Interagency Meeting
|
Meeting/ Workshop
|
AHRQ, CDC, CMS
|
CC, NHLBI, NIAID, NICHD, NIGMS
|
2019
|
|
Serum organochlorine/PCB concentrations and risk of prostate cancer in men from Ghana
|
Research Initiative
|
CDC
|
|
2022
|
|
Serum PFAS concentrations and risk of renal cell carcinoma in the Multiethnic Cohort
|
Research Initiative
|
CDC
|
|
2022
|
|
Severe Maternal Morbidity and Mortality (SMM&M) EHR Data Infrastructure Project
|
Other
|
ONC, CDC, ASPE
|
NICHD, NLM
|
2021
|
|
SHIELD Standardization of Lab Data to Enhance Outcomes Research and Value Based Care (SHIELD)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC
|
|
2019
|
|
Sickle Cell Disease Federal Interagency Work Group (SCD FIWG)
|
Committee, Advisory Group, or Work Group
|
FDA, CDC, HRSA, OASH
|
NHLBI
|
2019
|
|
Smokefree.gov Initiative
|
Resource Development
|
CDC, FDA, IHS
|
NIMHD
|
2003
|
|
Social Determinants of Health Interagency Policy Committee (SDOH-IPC)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, CDC, CMS, HRSA, SAMHSA, Other, ASPR
|
|
2021
|
|
Society for Prevention Research Annual Conference (SPR)
|
Meeting/ Workshop
|
CDC, ACF
|
NCCIH, NCI, NIDA
|
2017
|
|
State Cancer Profiles
|
Resource Development
|
CDC
|
|
2004
|
|
Subcommittee on Open Science (Formerly Interagency Working Group on Open Science)
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ASPR, CDC, CMS, FDA
|
NLM, OD/ OER, OD/ OSP
|
2013
|
|
Sudden Death in the Young (SDY) Registry
|
Resource Development
|
CDC, HRSA
|
NHLBI, NINDS
|
2013
|
|
SUDV Medical Countermeasures Acceleration Meeting
|
Committee, Advisory Group, or Work Group
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, HIS, SAMHSA
|
NIAID
|
|
|
Support for Implementation of Agency Public Access Policies
|
Resource Development
|
AHRQ, CDC, FDA, IOS, ASPR
|
OD/ OSP
|
2013
|
|
Surveillance, Epidemiology, and End Results (SEER) Program
|
Resource Development
|
CDC
|
|
1973
|
|
Synthetic DNA Working Group
|
Committee, Advisory Group, or Work Group
|
CDC, OS
|
OD/ OSP
|
2018
|
|
Systematized Nomenclature of Medicine-Clinical Terms (SNOMED CT)
|
Resource Development
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, IOS, SAMHSA
|
|
2003
|
|
|